Medical Aesthetics

Dr Mark Braschinsky

Olen lõpetanud Tartu Ülikooli arstiteaduskonna ja neuroloogia residentuuri 2006. aastal. Koheselt peale seda asusin tööle SA Tartu Ülikooli Kliinikum Närvikliinikusse, kus hetkel töötan vanemarst-õppejõuna neuroloogia erialal. Aastal 2010 kaitsesein teadusdoktori kraadi, peale mida alustasin oma spetsialiseerumist peavalude valdkonnas, luues SA TÜK Peavalukliiniku. 2011. aastal asutasin Eesti Peavalu Seltsi, mille president olen praeguseni.
Koheselt, kui aastal 2011 sai Botox ametliku näidustuse kroonilise migreeni raviks, alustasin Botox raviga Tartus, omades sellest ajast alates rikkalikku kogemust Botox raviga. Lisaks olen Euroopa Peavalu Föderatsiooni ja Rahvusvahelise Peavalu Seltsi juhatuse liige, mitme nii Eesti-sisese, kui ka rahvusvahelise teadustöö osaleja ja juhendaja ning mitmete publikatsioonide autor rahvusvahelistes eelretsenseeritavates teadusajakirjades.

Teadustöö, olulisemad PUBLIKATSIOONID, uuringud (viimased 10 a)

2018

Steiner TJ, Lipton RB; Lifting The Burden: The Global Campaign against Headache. The Headache-Attributed Lost Time (HALT) Indices: measures of burden for clinical management and population-based research. J Headache Pain. 2018 Feb 2;19(1):12. doi: 10.1186/s10194-018-0837-3.

Braschinsky M, Haldre S, Kals M, Arge M, Saar B, Niibek M, Katsarava Z, Steiner TJ. Structured education to improve primary-care management of headache: how long do the benefits last? A follow-up observational study.  Eur J Neurol. 2018 Mar;25(3):497-502. doi: 10.1111/ene.13524. Epub 2017 Dec 18.

2017

Vahtrik D, Vanahunt I, Tamela K, Braschinsky M. Postural correction and orthopaedic massage decrease migraine episodes and reduce headache attributed lost time. Cephalalgia 2017; 37(1S) 111.
Toom K, Raidvee A, Braschinsky M and PRILEVEL study group. Willingness to pay for effective headache treatment in Estonia – preliminary results. Cephalalgia 2017; 37(1S) 278.

Avi A, Vetkas A, Asser A, Braschinsky M, Asser T. Kolmiknärvineuralgiaga patsientide operatsioonijärgse elukvaliteedi muutuse hindamine. Eesti Arst 2017; 96(6):319–325.

Saar S, Rinken S, Mändul M, Braschinsky M. Kiirabi poolt migreenina käsitletud peavaluga patsiendid ja nende ravi. Eesti Arst 2017; 96(4):207–212.

2016

Braschinsky M, Raidvee A, Sabre L, Zmachinskaja N, Zukovskaja O, Karask A, Saar B, Rakitin A. 3D cinema and headache: The First evidential relation and analysis of involved Factors.  Front Neurol 2016 2016 Mar 23;7:30. doi: 10.3389/fneur.2016.00030.

Braschinsky M, Haldre S, Kals M, Ioofik A, Kivisild A, Korjas J, Koljal S, Katsarava Z, Steiner TJ. Structured education can improve primary-care management of headache: the first empirical evidence from a controlled interventional study. J Headache Pain Dec;17(1):24.

Schramm S, Uluduz D, Gouveia RG, Jensen R, Siva A, Uygunoglu U, Gvantsa G, Maka M, Braschinsky M, Filatova E, Skorobogatykh K, Osipova V, Azimova J, Straube A, Eren OE, Martelletti P, De Angelis V, Negro A, Linde M, Hagen K, Radojicic A, Zidverc-Trajkovic, Podgorac A, Paemeleire K, De Pue A, Lampl C, Steiner TJ, Katsarava Z. Headache service quality: Evaluation of quality indicators in 14 specialist-care centres. J Headache Pain. 2016 Dec;17(1):111.
Toom K, Laud T, Raidvee A, Braschinsky M. Promising Online Tool for Headache Epidemiology: The PRILEVEL Pilot Study. J Neurol Neurosurg 3(2): 126.

Sabre L, Rugo M, Asser T, Kõrv J, Braschinsky M. Headaches after traumatic spinal cord injury in Estonia. Cephalalgia 2016 Apr;36(5):403-12.
Brin V, Toom K, Braschinsky M. Migreeni hooravi Eestis vajab korrastamist. Eesti Arst 2016; 95(9):605–609.

Anderson K, Pärt M, Kals M, Haldre S, Vija V, Braschinsky M. Migreeniga inimeste elukvaliteet ning selle hindamine. Eesti Arst 2016;95(3):155–161.
Doktoritöö juhendamine: „Primaarsete peavalude levimus, nende seos levinumate riskifaktoritega ning peavaludega inimeste elukvaliteet Eestis”

2015

Toom K, Laud T, Braschinsky M. One questionnaire to diagnose most of the primary headaches: the PRILEVEL pilot study. Cephalalgia 2015; 35(65):154-5.
Mitsikostas D, Ashina M, Craven A, Diener HC, Goadsby PJ, Ferrari MD, Lampl C, Paemeleire K, Pascual J, Siva A, Olesen J, Osipova V, Martelletti P; EHF committee: Bendtsen, L, Bicakci, S, Braschinsky, M, Brossner, G, Constantinidis, T, Costa, C, Edvinsson, L, Freimane, A, Gantenbein, A, Gouveia, RG, Groseva, V, Hristova, S, Karli, N, Latysheva, N, Ljubisavljevic, S, Logina, I, Milanov, I, Obelleniene, D, Palavra, F, Parreira, E, Riederer, F, Sacco, S, Schytz, H, Sergeev, A, Steinber, A, Toom, K, Vikelis, M, Zebenholzer, K, Zidvec-Trajkovic, J. European headache federation consensus on technical investigation for primary headache disorders. J Headache Pain. 2015 Dec;17(1):5. doi: 10.1186/s10194-016-0596-y.

Polydefkis M, Arezzo J, Nash M, Bril V, Shaibani A, Gordon RJ, Bradshaw KL, Junor RW; Ranirestat Study Group. Safety and efficacy of ranirestat in patients with mild-to-moderate diabetic sensorimotor polyneuropathy. J Peripher Nerv Syst 2015 Dec;20(4):363-71.
Pärt M, Anderson K, Kals M, Braschinsky M. Which test to use to measure migraine’s burden and influence on everyday life? Cephalalgia 2015; 35(65):165-6.

Avi A, Vetkas A, Asser A, Braschinsky M, Asser T. Evaluation of postoperative change in quality of life in patients with trigeminal neuralgia. Cephalalgia 2015; 35(65):166.

2014

Braschinsky M. The global epidemiology of hereditary ataxia and spastic paraplegia: what are the messages? Neuroepidemiology. 2014;42(3):184-5.
Vahi P, Kals M, Kõiv L, Braschinsky M. Preoperative corticosteroid injections are associated with worse long-term outcome of surgical carpal tunnel release. Acta Orthop 2014 Feb;85(1):102-6.
Braschinsky M, Haldre S, Kals M, Iofik A, Kivisild A, Korjas J, Koljal S, Katsarava Z, Steiner TJ. Demonstrational project: to develop, implement and test an educational model for better headache-related primary health care. The Journal of Headache and Pain 2014;15(1),31.
Vilisaar J, Braschinsky M, Sinisalu V. Kroonilise valusündroomi praktiline käsitlus. Eesti Arst 2014; 93(5):269–274.
2013
Sabre L, Braschinsky M. Vestibulaarne migreen. Eesti Arst 2013; 92(5):279–282.

2012

Tomberg T, Braschinsky M, Rannikmäe K, Kepler J, Kepler K, Kõrv J, Linnamägi Ü, Asser T. Functional MRI of the cortical sensorimotor system in patients with hereditary spastic paraplegia. Spinal cord. 2012 Dec;50(12):885-890.
Vahter, L; Braschinsky, M; Haldre, S; Kool, P; Talvik, T; Gross-Paju, K. The prevalence of cognitive dysfunction in the estonian population of hereditary spastic paraplegia. World Journal of Neuroscience, 2012;2,91-97.

2011

Ling H, Braschinsky M, Taba P,Lüüs SM, Doherty K, Hotter A, Poewe W, Lees A. Decades of Delayed Diagnosis in 4 Levodopa-Responsive Young-Onset Monogenetic Parkinsonism Patients. Movement Disorders. 2011 DOI: 10.1002/mds.23563.

Braschinsky M, Rannikmäe K, Krikmann U, Lüüs SM, Raidvee A, Gross-Paju K, Haldre S. Health-related quality of life in patients with hereditary spastic paraplegia in Estonia. Spinal Cord. 2011;26(7):1337-40.

2010

Kaitstud doktoritöö “Hereditaarse spastilise parapleegia epidemioloogia Eestis, antud haigusega inimeste elukvaliteet ning geen-analüüsi juurutamine närvihaiguste diagnostikas”.
Braschinsky M, Zopp I, Kals M, Haldre S, Gross-Paju K. Bladder Dysfunction in Hereditary Spastic Paraplegia: What to Expect? J Neurol Neurosurg Psychiatry 2010;81:263-6.

Braschinsky M, Tamm R, Beetz C, Sachez-Ferrero E, Raukas E, Lüüs SM, Gross-Paju K, Boillot C, Canzian F, Metspalu A, Haldre S. Unique spectrum of SPAST variants in Estonian HSP patients: presence of benign missense changes but lack of exonic rearrangements. BMC Neurology 2010 doi:10.1186/1471-2377-10-17.

Braschinsky M, Rannikmäe K, Tamm R, Metspalu A, Gross-Paju K, Haldre S. Esimene hereditaarset spastilist parapleegiat süsteemselt käsitlenud uuring Eestis tõi esile originaalandmeid. Eesti Arst 2010
Braschinsky M, Tomberg T, Rannikmäe K, Kepler J, Kepler K, Kõrv J, Linnamägi Ü, Asser T. Sensomotoorse funktsiooni kortikaalne reorganistatsioon hereditaarse spastilise parapleegia korral. Tartu Ülikooli arstiteaduskonna aastapäeva teaduskonverents; 07.-08.10.2010, Tartu, Eesti. Stendettekanne.

2009

Braschinsky M, Lüüs S-M, Gross-Paju K, Haldre S. “The prevalence of hereditary spastic paraplegia and the occurence of SPG4 mutations in Estonia”. Neuroepidemiology 2009, 32:89-93.

Braschinsky M, Parts K, Maamägi H, Gross-Paju K, Haldre S. Functional assessment of lower extremities in hereditary spastic paraplegia. Arch Phys Med Rehabil. 2009 Nov;90(11):1887-90.

Vahter L, Braschinsky M, Haldre S, Gross-Paju K. The prevalence of depression in hereditary spasatic paraplegia. Clin Rehabil 2009 Sep;23(9):857-61.
Vahter L, Braschinsky M, Haldre S, Gross-Paju K. The prevalence of cognitive dysfunction in the Estonian population of hereditary spastic paraplegia. Neuropsychological Society Midsummer meeting. Helsinki, Finland, 29-31 August 2009. Stendettekanne.

Retsensent rahvusvahelistes tsiteeritavates ajakirjades
Cephalalgia, Neuroepidemiology, Synapce, European Archives of Psychiatry and Clinical Neuroscience, BMC Neurology, British Medical Journal, European Urology